Literature DB >> 8061106

Hyperphosphatemia in multiple myeloma.

S Oren1, A Feldman, S Turkot, G Lugassy.   

Abstract

We report three cases of IgG kappa multiple myeloma with pseudohyperphosphatemia. The patients' serum calcium levels were normal, and the hyperphosphatemia was not related to impaired renal function. No hypoparathyroidism was found, and no exogenous phosphate preparation had been given. Since the hyperphosphatemia was of no obvious clinical or physiological significance, as evidenced by normal serum levels of 1,25 dihydroxy vitamin D3, it was diagnosed as spurious and was connected to interference of the paraprotein with the chromogenic assay. In two of the patients major fluctuations in serum phosphate levels were seen, induced by the changes in globulin and paraprotein levels that occurred during therapy and relapse.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8061106     DOI: 10.1007/bf01757346

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  12 in total

1.  Renal function in patients with multiple myeloma.

Authors:  R A DeFronzo; C R Cooke; J R Wright; R L Humphrey
Journal:  Medicine (Baltimore)       Date:  1978-03       Impact factor: 1.889

2.  Paraprotein interference with colorimetry of phosphate in serum of some patients with multiple myeloma.

Authors:  M Sonnenblick; U Eylath; R Brisk; C Eldad; C Hershko
Journal:  Clin Chem       Date:  1986-08       Impact factor: 8.327

3.  Immunoglobulin interference with phosphorus and chloride determinations with the Coulter Chemistry.

Authors:  R A Landowne
Journal:  Clin Chem       Date:  1979-06       Impact factor: 8.327

4.  Phosphate binding by a myeloma protein.

Authors:  T Pettersson; L Hortling; A M Teppo; K J Tötterman; F Fyhrquist
Journal:  Acta Med Scand       Date:  1987

5.  Multiple myeloma: review of 869 cases.

Authors:  R A Kyle
Journal:  Mayo Clin Proc       Date:  1975-01       Impact factor: 7.616

6.  Pseudohyperphosphatemia and dysproteinemia.

Authors:  J C Busse; M A Gelbard; J J Byrnes; R Hellman; C A Vaamonde
Journal:  Arch Intern Med       Date:  1987-11

7.  [Spurious hyperphosphatemia in multiple myeloma].

Authors:  I Jarchovsky; H Beitner; L Plavnick
Journal:  Harefuah       Date:  1991-12-15

8.  Multiple myeloma masquerading as metastatic breast cancer.

Authors:  D Savage; T J Garrett
Journal:  Cancer       Date:  1986-03-01       Impact factor: 6.860

9.  Spurious hyperphosphatemia due to hyperlipidemia.

Authors:  D J Leehey; J T Daugirdas; T S Ing; R W Reid
Journal:  Arch Intern Med       Date:  1985-04

10.  Hyperglobulinemia may spuriously elevate measured serum inorganic phosphate levels.

Authors:  S G Adler; S A Laidlaw; M M Lubran; J D Kopple
Journal:  Am J Kidney Dis       Date:  1988-03       Impact factor: 8.860

View more
  1 in total

1.  Pseudohyperphosphatemia in a patient with multiple myeloma.

Authors:  Yonggu Lee; Taiyon Koo; Joo-Hark Yi; Jung-Hye Choi; Sang-Woong Han; Ile-Kyu Park; Ho-Jung Kim
Journal:  Electrolyte Blood Press       Date:  2007-12-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.